Episode Details

Back to Episodes

New Standard of Care in Melanoma? Neoadjuvant Immunotherapy Offers ”Fantastic” Potential, Expert Says

Published 1 year, 9 months ago

Description

From ASCO 2024

New Standard of Care in Melanoma? Neoadjuvant Immunotherapy Offers "Fantastic" Potential, Expert Says.

Dr. Robert Figlin speaks with Dr. Christian Blank from Leiden University

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.